Literature DB >> 1383617

Contractile actions of endothelin-1 in isolated helical strips from rat pulmonary artery: potentiation of serotonin-induced contraction.

H Itoh1, N Hiraoka, H Higuchi, M Ito, T Konishi, T Nakano.   

Abstract

Endothelin-1 (ET-1) caused a concentration-dependent contraction of helical strips from rat pulmonary arteries. Removal of endothelial cells did not change the response to ET-1. ET-1 (10(-8) M) induced a small contraction of the arterial strips in the absence of extracellular Ca2+ (31.0% of the contraction in the presence of extracellular Ca2+). Pretreatment of pulmonary arterial strips with 6 x 10(-11) M ET-1 potentiated the serotonin-induced contraction (10(-7)-3 x 10(-6) M), but showed no significant effect on KCl-induced contraction. The ET-1-induced potentiation of the response to serotonin was prevented by nordihydroguaiaretic acid (3 x 10(-6) M), quinacrine (10(-6) M), and AA861 (10(-6) M), but not by indomethacin (10(-7) M) and baicalein (10(-6) M). These results suggest that ET-1 may cause pulmonary hypertension through a direct vasoconstrictor action and potentiation of serotonin-induced contraction, which may involve the 5-lipoxygenase pathway.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383617

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

1.  EndothelinB receptor-mediated contraction in human pulmonary resistance arteries.

Authors:  K M McCulloch; C C Docherty; I Morecroft; M R MacLean
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Haemodynamic and energetic properties of stunned myocardium in rabbit hearts.

Authors:  J D Schipke; B Korbmacher; A Dorszewski; G Selcan; U Sunderdiek; G Arnold
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

3.  Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.

Authors:  K W Buchan; C Alldus; C Christodoulou; K L Clark; C W Dykes; M J Sumner; D M Wallace; D G White; I S Watts
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.